CD8A and cancer: IK14004 enhances expression of both activating co-receptors in CD8+ T cells including granzyme B expression and, given the relevance of these co-receptors in cancer immunotherapy82,83, we cannot exclude the possibility of an indirect immune-related effect of IK14004 on tumour growth.